MyAverix Finance
SHG · Healthcare
Henan Lingrui Pharmaceutical Co Ltd (600285)
Drug Manufacturers - Specialty & Generic
Henan Lingrui Pharmaceutical Co Ltd (600285) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $12.64B, P/E ratio is 15.91, net margin is 21.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600285
Henan Lingrui Pharmaceutical Co Ltd (600285) — FAQ
What is Henan Lingrui Pharmaceutical Co Ltd's market cap?
Henan Lingrui Pharmaceutical Co Ltd (600285) has a reported market cap of $12.64B (data as of 2026-03-28).
What is 600285's P/E ratio?
The price-to-earnings (P/E) ratio for Henan Lingrui Pharmaceutical Co Ltd (600285) is 15.91 (data as of 2026-03-28).
Does Henan Lingrui Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Henan Lingrui Pharmaceutical Co Ltd (600285). Check the MyAverix Finance app for the latest dividend data.
What sector is Henan Lingrui Pharmaceutical Co Ltd in?
Henan Lingrui Pharmaceutical Co Ltd (600285) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600285 listed on?
600285 is listed on SHG.
What is Henan Lingrui Pharmaceutical Co Ltd's net margin?
Henan Lingrui Pharmaceutical Co Ltd (600285) reports a net margin of 21.1% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.